Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Characteristics, Oncogenic Roles, and Relevant Immune and Pharmacogenomic Features of EVA1B in Colorectal Cancer

16 Feb 2022

Abstract excerpt

OBJECTIVE: EVA1B, a protein coding gene, is a critical paralog of EVA1A gene. Herein, our study was conducted to investigate the role of EVA1B in colorectal cancer (CRC) progression and prognosis. METHODS: Pan-cancer analysis was conducted to analyze expression, genetic and epigenetic alterations, and immunological characteristics of EVA1B. Especially, immunological characteristics and mutational landscape were...

Topics

Join the communities discussing this publication.

Cancer Immunotherapy and Biomarkers
Clusterin in disease pathology
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35250982
DOI: 10.3389/fimmu.2022.809837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Characteristics, Oncogenic Roles, and Relevant Immune and Pharmacogenomic Features of EVA1B in Colorectal CancerPMID 35250982Read ↗

RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation.Semantic proximity Read ↗

HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcomeSemantic proximity Read ↗

CAV1 Impacts the Tumor Immune Microenvironment and Has Potential Value of Predicting Response to Immunotherapy in Esophageal CancerSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.Semantic proximity Read ↗

VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8 <sup>+</sup> T cell killing in colorectal cancerSemantic proximity Read ↗

A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinomaSemantic proximity Read ↗

Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor formation and progressionSemantic proximity Read ↗

Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinomaSemantic proximity Read ↗

Overexpression of Evi‐1 oncoprotein represses TGF‐β signaling in colorectal cancerSemantic proximity Read ↗

Deciphering the multidimensional impact of IGFBP1 expression on cancer prognosis, genetic alterations, and cellular functionality: A comprehensive Pan-cancer analysisSemantic proximity Read ↗

Novel exosome-associated LncRNA model predicts colorectal cancer prognosis and drug responseSemantic proximity Read ↗

VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.